Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 328 citing articles:

Combination strategies with PD-1/PD-L1 blockade: current advances and future directions
Ming Yi, Xiaoli Zheng, Mengke Niu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 828
New opportunities and challenges of natural products research: When target identification meets single-cell multiomics
Yuyu Zhu, Zijun Ouyang, Haojie Du, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 11, pp. 4011-4039
Open Access | Times Cited: 243
Gut Microbiota-Derived Tryptophan Metabolites Maintain Gut and Systemic Homeostasis
Lei Su, Yunhuan Gao, Rongcun Yang
Cells (2022) Vol. 11, Iss. 15, pp. 2296-2296
Open Access | Times Cited: 186
Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications
Lin-Yong Zhao, Jia-Xin Mei, Gang Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 150
FDX1 can Impact the Prognosis and Mediate the Metabolism of Lung Adenocarcinoma
Zeyu Zhang, Yarui Ma, Xiaolei Guo, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 135
Gut Microbiota Modulation of Efficacy and Toxicity of Cancer Chemotherapy and Immunotherapy
Despoina Chrysostomou, Lauren A. Roberts, Julian R. Marchesi, et al.
Gastroenterology (2022) Vol. 164, Iss. 2, pp. 198-213
Open Access | Times Cited: 131
Current Landscape of Therapeutic Resistance in Lung Cancer and Promising Strategies to Overcome Resistance
Adnin Ashrafi, Zakia Akter, Pouya Modareszadeh, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4562-4562
Open Access | Times Cited: 68
Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma
Laura A. Bolte, Karla A. Lee, Johannes R. Björk, et al.
JAMA Oncology (2023) Vol. 9, Iss. 5, pp. 705-705
Open Access | Times Cited: 44
Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target
Mengwei Zhang, Jinkai Liu, Qiang Xia
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 44
Role of the microbiota in response to and recovery from cancer therapy
Stephen J. Blake, Yochai Wolf, Ben Boursi, et al.
Nature reviews. Immunology (2023) Vol. 24, Iss. 5, pp. 308-325
Closed Access | Times Cited: 41
Modulating gut microbiome in cancer immunotherapy: Harnessing microbes to enhance treatment efficacy
Xing Kang, Harry Cheuk-Hay Lau, Jun Yu
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101478-101478
Open Access | Times Cited: 39
Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies
Jindong Xie, Manqing Liu, Xinpei Deng, et al.
iMeta (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 31
Critical role of the gut microbiota in immune responses and cancer immunotherapy
Ze-Hua Li, Weixi Xiong, Liang Zhu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 30
The regulatory effect of polysaccharides on the gut microbiota and their effect on human health: A review
Hongkun Xue, Beimeng Liang, Yu Wang, et al.
International Journal of Biological Macromolecules (2024) Vol. 270, pp. 132170-132170
Closed Access | Times Cited: 28
Crosstalk between metabolism and cell death in tumorigenesis
Shichao Yang, Caden Hu, Xiaomei Chen, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 24
Ganoderma lucidum Polysaccharide Supplementation Significantly Activates T-Cell-Mediated Antitumor Immunity and Enhances Anti-PD-1 Immunotherapy Efficacy in Colorectal Cancer
Wenshuai Li, Qi Zhou, Bin Lv, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 21, pp. 12072-12082
Closed Access | Times Cited: 19
Fecal microbiota transplantation: no longer cinderella in tumour immunotherapy
Yunwei Yang, Yaping An, Yue Dong, et al.
EBioMedicine (2024) Vol. 100, pp. 104967-104967
Open Access | Times Cited: 18
Gut microbiome affects the response to immunotherapy in non‐small cell lung cancer
Shengnan Ren, Lingxin Feng, Haoran Liu, et al.
Thoracic Cancer (2024) Vol. 15, Iss. 14, pp. 1149-1163
Open Access | Times Cited: 17
Selective utilization of medicinal polysaccharides by human gut Bacteroides and Parabacteroides species
Zepeng Qu, Hongbin Liu, Yang Ji, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 3
New insights into natural products that target the gut microbiota: Effects on the prevention and treatment of colorectal cancer
Lu Lu, Jiahuan Dong, Yujing Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 61
Gut Microbiota: Therapeutic Targets of Ginseng Against Multiple Disorders and Ginsenoside Transformation
Zhaoqiang Chen, Zepeng Zhang, Jiaqi Liu, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 56
Metagenomic and metabolomic analyses reveal synergistic effects of fecal microbiota transplantation and anti-PD-1 therapy on treating colorectal cancer
Jiayuan Huang, Zheng Xing, Wanying Kang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 42
Lycium barbarum Glycopeptide prevents the development and progression of acute colitis by regulating the composition and diversity of the gut microbiota in mice
Yi‐Chun Huang, Yinghui Zheng, Fengmei Yang, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 39
Fecal microbiota transplantation plus tislelizumab and fruquintinib in refractory microsatellite stable metastatic colorectal cancer: an open-label, single-arm, phase II trial (RENMIN-215)
Wensi Zhao, Jun Lei, Shaobo Ke, et al.
EClinicalMedicine (2023) Vol. 66, pp. 102315-102315
Open Access | Times Cited: 38
Polysaccharide‐Based Stimulus‐Responsive Nanomedicines for Combination Cancer Immunotherapy
Qiuxia Li, Xing Liu, Chunmei Yan, et al.
Small (2023) Vol. 19, Iss. 23
Closed Access | Times Cited: 37
Page 1 - Next Page

Scroll to top